Effectiveness of two and three mRNA COVID-19 vaccine doses against Omicron- and Delta-Related outpatient illness among adults, October 2021-February 2022.
Kim SS, Chung JR, Talbot HK, Grijalva CG, Wernli KJ, Kiniry E, Martin ET, Monto AS, Belongia EA, McLean HQ, Gaglani M, Mamawala M, Nowalk MP, Moehling Geffel K, Tartof SY, Florea A, Lee JS, Tenforde MW, Patel MM, Flannery B; Strain Surveillance and Emerging Variants Team; Bentz ML, Burgin A, Burroughs M, Davis ML, Howard D, Lacek K, Madden JC, Nobles S, Padilla J, Sheth M.
Kim SS, et al. Among authors: moehling geffel k.
Influenza Other Respir Viruses. 2022 Nov;16(6):975-985. doi: 10.1111/irv.13029. Epub 2022 Jul 29.
Influenza Other Respir Viruses. 2022.
PMID: 36825251
Free PMC article.